Evidence map›Paper›PMID 37570012›Full record

ArticleMaterials (Basel, Switzerland)2023

Iron Selenide Particles for High-Performance Supercapacitors.

Davide Scarpa, Claudia Cirillo, Eleonora Ponticorvo, Carla Cirillo, Carmine Attanasio, Mariagrazia Iuliano, Maria Sarno

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Davide ScarpaDepartment of Physics "E.R. Caianiello", University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.ORCID 0000-0002-4739-4540
Claudia CirilloDepartment of Physics "E.R. Caianiello", University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.ORCID 0000-0002-7492-3831
Eleonora PonticorvoDepartment of Physics "E.R. Caianiello", University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.
Carla CirilloCNR-SPIN, c/o University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.ORCID 0000-0001-8755-4484
Carmine AttanasioDepartment of Physics "E.R. Caianiello", University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.ORCID 0000-0002-3848-9169
Mariagrazia IulianoDepartment of Physics "E.R. Caianiello", University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.
Maria SarnoDepartment of Physics "E.R. Caianiello", University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.ORCID 0000-0001-5663-3040

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, iron (II) selenide (FeSe), which has been widely studied for years to unveil the high-temperature superconductivity in iron-based superconductors, is drawing increasing attention in the electrical energy storage (EES) field as a supercapacitor electrode because of its many advantages. In this study, very small FeSe particles were synthesized via a simple, low-cost, easily scalable, and reproducible solvothermal method. The FeSe particles were characterized using cyclic voltammetry (CV), galvanostatic charge/discharge (GCD) measurements, and electrochemical impedance spectroscopy (EIS), revealing enhanced electrochemical properties: a high capacitance of 280 F/g at 0.5 A/g, a rather high energy density of 39 Wh/kg and a corresponding power density of 306 W/kg at 0.5 A/g, an extremely high cycling stability (capacitance retention of 92% after 30,000 cycles at 1 A/g), and a rather low equivalent series resistance (R

Indexed as

energy densityFeSehigh capacitancemetal selenide electrode

Identifiers

PMID37570012
PMCPMC10419825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.